Gilteritinib

Category: Cancer



Gilteritinib Overview

Gilteritinib is a cancer drug.[1] It acts as an inhibitor of AXL receptor tyrosine kinase.[2] It was developed by Astellas Pharma. In April 2018, Astellas filed a new drug application with the Food and Drug Administration for gilteritinib for the treatment of adult patients with FLT3 mutation–positive relapsed or refractory acute myeloid leukemia (AML).[3] In November 2018, the FDA approved gilteritinib for treatment of adult patients wi...

Read more Gilteritinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gilteritinib

Recent Gilteritinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gilteritinib
  • Tablet: 40mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Gilteritinib or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA